Biocon acquires oral solid dosage manufacturing facility of Eywa Pharma for US$7.7 million
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Need to harmonize traditional and modern medicine to combat alarming health problems
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
Aims to foster a Resilient and Sustainable Healthcare Ecosystem
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Subscribe To Our Newsletter & Stay Updated